| 1. |
- Guo, Yaxiao, et al.
(författare)
-
Boosting nitrogen reduction reaction by bio-inspired FeMoS containing hybrid electrocatalyst over a wide pH range
- 2019
-
Ingår i: Nano Energy. - : Elsevier. - 2211-2855 .- 2211-3282. ; 62, s. 282-288
-
Tidskriftsartikel (refereegranskat)abstract
- A facile preparation of bio-inspired and morphology controllable catalytic electrode FeS@MoS2/CFC, featuring a carbon fiber cloth (CFC) covered with FeS dotted MoS2 nanosheets, has been established. Synergy between the CFC as a self-standing conductive substrate and the FeS nanoparticle dotted MoS2 nanosheets with abundant active sites makes the noble-metal-free catalytic electrode FeS@MoS2/CFC highly efficient in nitrogen reduction reaction (NRR), with an ammonia production rate of 8.45 mu g h(-1) cm(-2) and excellent long-term stability at -0.5 V in pH neutral electrolyte. Further electrolysis in acidic and alkaline electrolytes revealed the overall NRR catalytic activity of this electrode over a wide pH range.
|
|
| 2. |
- Guo, Yaxiao, et al.
(författare)
-
Molybdenum and boron synergistically boosting efficient electrochemical nitrogen fixation
- 2020
-
Ingår i: Nano Energy. - : Elsevier Ltd. - 2211-2855 .- 2211-3282. ; 78
-
Tidskriftsartikel (refereegranskat)abstract
- Ammonia production consumes ~2% of the annual worldwide energy supply, therefore strategic alternatives for the energy-intensive ammonia synthesis through the Haber-Bosch process are of great importance to reduce our carbon footprint. Inspired by MoFe-nitrogenase and the energy-efficient and industrially feasible electrocatalytic synthesis of ammonia, we herein establish a catalytic electrode for artificial nitrogen fixation, featuring a carbon fiber cloth fully grafted by boron-doped molybdenum disulfide (B-MoS2/CFC) nanosheets. An excellent ammonia production rate of 44.09 μg h–1 cm–2 is obtained at −0.2 V versus the reversible hydrogen electrode (RHE), whilst maintaining one of the best reported Faradaic efficiency (FE) of 21.72% in acidic aqueous electrolyte (0.1 M HCl). Further applying a more negative potential of −0.25 V renders the best ammonia production rate of 50.51 μg h–1 cm–2. A strong-weak electron polarization (SWEP) pair from the different electron accepting and back-donating capacities of boron and molybdenum (2p shell for boron and 5d shell for molybdenum) is proposed to facilitate greatly the adsorption of non-polar dinitrogen gas via N≡N bond polarization and the first protonation with large driving force. In addition, for the first time a visible light driven photo-electrochemical (PEC) cell for overall production of ammonia, hydrogen and oxygen from water + nitrogen, is demonstrated by coupling a bismuth vanadate BiVO4 photo-anode with the B-MoS2/CFC catalytic cathode.
|
|
| 3. |
- Li, Lanfen, et al.
(författare)
-
Structural genomics studies of human caries pathogen Streptococcus mutans
- 2014
-
Ingår i: Journal of Structural and Functional Genomics. - : Springer Science and Business Media LLC. - 1345-711X .- 1570-0267. ; 15:3, s. 9-91
-
Tidskriftsartikel (refereegranskat)abstract
- Gram-positive bacterium Streptococcus mutans is the primary causative agent of human dental caries. To better understand this pathogen at the atomic structure level and to establish potential drug and vaccine targets, we have carried out structural genomics research since 2005. To achieve the goal, we have developed various in-house automation systems including novel high-throughput crystallization equipment and methods, based on which a large-scale, high-efficiency and low-cost platform has been establish in our laboratory. From a total of 1,963 annotated open reading frames, 1,391 non-membrane targets were selected prioritized by protein sequence similarities to unknown structures, and clustered by restriction sites to allow for cost-effective high-throughput conventional cloning. Selected proteins were over-expressed in different strains of Escherichia coli. Clones expressed soluble proteins were selected, expanded, and expressed proteins were purified and subjected to crystallization trials. Finally, protein crystals were subjected to X-ray analysis and structures were determined by crystallographic methods. Using the previously established procedures, we have so far obtained more than 200 kinds of protein crystals and 100 kinds of crystal structures involved in different biological pathways. In this paper we demonstrate and review a possibility of performing structural genomics studies at moderate laboratory scale. Furthermore, the techniques and methods developed in our study can be widely applied to conventional structural biology research practice.
|
|
| 4. |
- Liu, Anbu, et al.
(författare)
-
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
- 2024
-
Ingår i: Molecular Carcinogenesis. - 0899-1987. ; 63:1, s. 75-93
-
Tidskriftsartikel (refereegranskat)abstract
- Gastrointestinal stromal tumors (GISTs) are predominantly initiated by KIT mutations. In this study, we observed that discoidin domain receptors 1 and 2 (DDR1 and DDR2) exhibited high expression in GISTs, were associated with KIT, and enhanced the activation of both wild-type KIT and primary KIT mutants. Inhibition of DDR1/2 led to a reduction in the activation of KIT and its downstream signaling molecules, ultimately impairing GIST cell survival and proliferation in vitro. Consequently, treatment of mice carrying germline KIT/V558A mutation with DDR1/2 inhibitor significantly impeded tumor growth, and the combined use of DDR1/2 inhibitor and imatinib, the first-line targeted therapeutic agent for GISTs, markedly enhanced tumor growth suppression. In addition, DDR1/2 inhibition resulted in decreased KIT expression, while KIT inhibition led to upregulation of DDR1/2 expression in GISTs. The presence of DDR1/2 also decreased the sensitivity of wild-type KIT or primary KIT mutants to imatinib, indicating a possible role for DDR1/2 in promoting GIST survival during KIT-targeted therapy. The development of drug-resistant secondary KIT mutations is a primary factor contributing to GIST recurrence following targeted therapy. Similar to primary KIT mutants, DDR1/2 can associate with and enhance the activation of secondary KIT mutants, further diminishing their sensitivity to imatinib. In summary, our data demonstrate that DDR1/2 contribute to KIT activation in GISTs and strengthen resistance to imatinib for both primary and secondary KIT mutants, providing a rationale for further exploration of DDR1/2 targeting in GIST treatment.
|
|
